Clinician scientists within Infectious Diseases, along with principal investigators in the Center for Vaccines and Immunity and the Center for Microbial Pathogenesis at The Abigail Wexner Research Institute, are dedicated to improving care for children with infectious diseases. Laboratory and clinical-based research studies are informing new treatment strategies by revealing how bacteria and viruses affect children’s immune systems.
Clinician scientists collaborate to use virus-specific T-cells from the mother to successfully treat a systemic adenovirus infection in a preterm infant.
CMV is the leading non-genetic cause of sensorineural hearing loss in infancy and childhood. Identification of newborns with congenital CMV infection can improve their outcomes by early intervention programs and/or antiviral treatment.
Michael Brady, MD, an Infectious Diseases specialist at Nationwide Children’s Hospital, answers this common question from primary care providers.
The finding has important implications for identifying cases in which infants may not need invasive medical care such as spinal taps, antibiotics or hospitalizations.
